| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Curanex Pharmaceuticals Inc | Secretary, 10%+ Owner | Common Stock | 7,076,160 | 25 Aug 2025 | Indirect | ||
| Curanex Pharmaceuticals Inc | Secretary, 10%+ Owner | Common Stock | 3,248,400 | 25 Aug 2025 | Direct | ||
| Curanex Pharmaceuticals Inc | Secretary, 10%+ Owner | Series A Preferred Stock | 490,000 | 25 Aug 2025 | Indirect | ||
| Curanex Pharmaceuticals Inc | Secretary, 10%+ Owner | Series A Preferred Stock | 200,000 | 25 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000164117225026280-jing-dian-ying-2025-08-25 | Curanex Pharmaceuticals Inc | 25 Aug 2025 | 0 | $0 | 3 | Secretary, 10%+ Owner | 02 Sep 2025, 20:30 |